SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Small Cap Foreign Biotech
An SI Board Since January 2000
Posts SubjectMarks Bans
363 30 0
Emcee:  RWReeves Type:  Unmoderated
Introduction Compact
Small Cap Foreign Biotech, with a few exceptions, is not well known in the US. This year, QLTI brought renewed interest to the Canadian small cap sector, and some foreign biotechs have actually joined the recent US rally successfully. There is some pretty interesting work going on around the globe, and much of it selling at capitalizations a lot less than US. Stock markets across the world work differently than in the US and US investors need all the help we can get to access and understand them. This access is expanding almost daily.

Since the rules are different overseas, this thread is intended to be a forum for discussion of foreign biotechs and medical device companies and hopefully to add information to what is often poorly reported for investment purposes. A model portfolio may be tough to build as SI will probably fall flat on quotes outside of the OTCBB, or ADR's.

Disclosures: I work for a privately held biotech company with interests outside the US. Of course I won't disclose anything but public information about any of the firms I/we work with and won't discuss at all any we have an interest in.

Generally, to keep the tables honest, please disclose your interest in firms and issues which you discuss, and let's keep pumping to a minimum and info/dialogue high.

While this should not need to be said, don't invest in ANYTHING without doing your own homework and knowing what you bought (or sold) and why.

That said I look forward to some pretty interesting discussions.

RWR
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
363Anyone following PSTI?CrazyTrain-4/26/2011
362Mesoblast still going strong.CrazyTrain-4/26/2011
361>>I was complaining about mdvn and mygn, respectively.<< Oh, OK. Ituck-3/3/2010
360and while you're considering a new valuation for mdvn, don't know if thiscaram(o)uche-3/3/2010
359Ouch! Sure hope you haven't done anything after hours. Don't expect coscaram(o)uche-3/3/2010
358"an old antibiotic, an old NSAID......." Nor are they kind of enough tuck-3/3/2010
357an old antibiotic, an old NSAID..... and a bunch of outrageous contortions or scaram(o)uche-3/3/2010
356A rather shameless attempt to capitalize on Medivation's AD woes by this swituck-3/3/2010
355Nice call at $1.38 looks like it is consolidating in the $1.80'sCrazyTrain-2/4/2010
354Mesoblast - another 52 week closing high at $2.01 (AU) MSB.AX . Anyone else getCrazyTrain-1/13/2010
353Mesoblast Limited MSB.AX - adult stem cell patents. Incredible potential - must CrazyTrain-12/19/2009
352Medivir: Lipsovir(R) Has Entered Phase III Clinical Study By Business Wire STOCnigel bates-7/6/2006
351Karo Bio Presents New Important Advances at its Annual R&D Day 29 March 2006nigel bates-3/30/2006
350Patent application submitted regarding the mode of action for quinoline compoundnigel bates-3/27/2006
349Biodegrable CMC Spacers for Basal Thumb OA Drive Growth at Small Bone InnovationIcebrg-3/27/2006
348NicOx 2005 Financial Results: Strong Revenue Growth and Solid Progress with Clinnigel bates-3/1/2006
347Artelon® nanofibers successfully used as coating on metal implants PercutIcebrg-10/28/2005
346Effects of Skyepharma meltdown- If you take a careful look through their annualf_mcknuckles-9/30/2005
345<pre>Evolutec Group plc (AIM: EVC), a biopharmaceutical company engaged innigel bates-3/23/2005
344NicOx Reports 2004 Financial Results By Business Wire NicOx S.A. (Eurolist:Nnigel bates-3/1/2005
343<i>Quite a few small companies will be reviewing their NASDAQ listings, thnigel bates-2/25/2005
342Biofocus renewed their Amgen chemistry deal last week, and announced another litnigel bates-1/21/2005
341Karo Bio shares jump on Merck milestone payment Fri Jan 21, 2005 04:35 AM ET STkeokalani'nui-1/21/2005
340GSK Terminates MIV-210 Partnership -- Medivir to Initiate Phase II Trial HUDDInigel bates-12/27/2004
339European Bio Pharmaceutical Leader Announces Cancer Vaccine Research Subsidiary Icebrg-12/17/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News